Arkolith/Insider Trading/RNAC/Form 4

Kurtoglu Metin

Chief Technology OfficerCartesian Therapeutics, Inc. (RNAC) · full profile →Form 4 · filed Jan 7, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$82K
Net Open-Market Flow
-$82K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 6, 2025Sell(S)2K$16.83$41K62K
Jan 3, 2025Sell(S)2K$16.72$40K65K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001453687-25-000040) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML